GlassScriptPhysician profile
Deanna M Angers
NPI 1689163073
$4,191.18
in general payments reported to CMS, 2019-2025
19 companies · $460 in 2025
The $460 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $57.88 · 2023: $3,272 · 2024: $402 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,085 · Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,084.99 |
| Food and Beverage | $1,048.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,008.98 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Biogen, INC. | $222.27 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $175.49 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $124.34 | 2023-2025 | Myfembree |
| Abbvie INC. | $119.22 | 2022-2025 | Orilissa, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $101.82 | 2023-2025 | |
| Femselect INC. | $79.62 | 2025 | Enplace |
| Aspira Women'S Health INC | $72.41 | 2024 | Ova1 |
| Coopersurgical, INC. | $48.09 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $45.18 | 2023-2024 | Nexplanon, Nuvaring |
| Vertex Pharmaceuticals Incorporated | $39.51 | 2024-2025 | |
| Baxter Healthcare | $29.44 | 2023 | Tisseel |
| Exact Sciences Corporation | $21.06 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $20.53 | 2024 | Aptima |
| Pfizer INC. | $19.27 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.18 | 2024 | Gardasil 9, Gardasil |
| Daiichi Sankyo INC. | $16.46 | 2023 | Injectafer |
| Minerva Surgical, INC | $15.20 | 2024 | |
| Axonics, INC. | $15.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Angers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.